Drawing for GIVING FLIGHT TO RESEARCH

USPTO serial 77797401

GIVING FLIGHT TO RESEARCH

Reviewed by CopyMark Law Group

Reg. 3939522Status 710
Filing date
Status date
Registration date
Apr 5, 2011
Examiner
MCCAULEY, BRENDAN D
Law office
TMO LAW OFFICE 114

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with GIVING FLIGHT TO RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura M. Kelley

LAURA M. KELLEY MYERS BIGEL, PA4140 PARKLAKE AVE STE 600RALEIGH, NC 27612-3730UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Computerized database management services for others in the areas of medical research, pharmaceutical research and product regulatory approval, and public health, and health care; computerized database management services for others in relation to the research, development, and testing of new medical products and devices; computerized administration services encompassing the randomization of clinical drug trial participants; Providing technical consultation in the areas of product regulatory approval in the nature of business consulting and management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval, providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval and consulting services in the field of medical product approval for commercial purposesSECTION 8 - CANCELLEDJun 18, 2009
041Providing online, non-downloadable electronic publications, namely, manuals for use with computer software that acquires, tracks, retrieves, validates, summarizes, statistically analyzes, and presents data used in the areas of medical research, pharmaceutical research and product regulatory approval, public health, health care, and in relations to the research, development, and testing of new medical products and devicesSECTION 8 - CANCELLEDJun 18, 2009
042Consulting services, namely, providing technical consultation in the areas of medical research and pharmaceutical research; Providing technical consultation and research services in relation to the research, development, and testing of new medical products and devices; Scientific and medical research consulting services in the nature of collecting, analyzing, and reporting clinical trial data, public health research data, and health care research data; Customization of software for others for use in connection with the acquisition, tracking, retrieval, validation, summarization, and statistical analysis and presentation of data used in areas of medical research, pharmaceutical research and product regulatory approval, public health, health care, and in relation to the research, development, and testing of new medical products and devices; Providing online, non-downloadable computer software, specifically software for use in connection with the acquisition, tracking, retrieval, validation, summarization, and statistical analysis and presentation of data used in areas of medical research, pharmaceutical research and product regulatory approval, public health, health care, and in relation to the research, development, and testing of new medical products and devicesSECTION 8 - CANCELLEDJun 18, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Apr 5, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 23, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 23, 2017C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 23, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 16, 2016E815TEAS SECTION 8 & 15 RECEIVED
Apr 5, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 18, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 29, 2010NPUBNOTICE OF PUBLICATION
Dec 13, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 10, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 28, 2010PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY
May 18, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 17, 2010ALIEASSIGNED TO LIE
May 7, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 12, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 12, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2009DOCKASSIGNED TO EXAMINER
Aug 10, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 8, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance